CLEOPATTRA: Effects of NNC6019-0001 versus placebo on cardiovascular outcomes in participants with transthyretin amyloid cardiomyopathy (ATTR-CM)

Hare, James (Primary Chief Investigator (PCI))

Medicine Alfred Hospital

Project: Research

Short title	CLEOPATTRA
Status	Active
Effective start/end date	30/01/26 → 29/01/30

Keywords

clinical trials
transthyretin amyloid cardiomyopathy
cardiovascular diseases

Clinical Trial Phase

Phase III (a & b)
External Sponsor